Cialis Use Tied to Higher Glaucoma Risk in Large Study

New findings from a large observational study suggest that men taking tadalafil — the medication sold under the brand name Cialis — may face an elevated risk of developing open-angle glaucoma, the most common form of the disease. The research adds to a growing body of evidence examining whether PDE5 inhibitors, a class of drugs used primarily for erectile dysfunction, carry hidden effects on eye health.

Glaucoma damages the optic nerve, often silently, and is a leading cause of irreversible vision loss worldwide. The suspected link between tadalafil and glaucoma centers on blood flow: PDE5 inhibitors relax blood vessels, and the optic nerve depends on a delicate balance of ocular pressure and circulation. Some researchers hypothesize that repeated use of these drugs could disturb that balance over time, though the precise mechanism remains unproven.

What This Means for Patients

It is important to interpret these results with caution. Observational studies can reveal associations but cannot prove that tadalafil directly causes glaucoma. Men who use these medications tend to be older — the same demographic already at higher baseline risk for the disease — and other health factors may play a role. The findings do not mean that every user will develop glaucoma, nor do they suggest that anyone should abruptly stop a prescribed medication.

For anyone taking tadalafil, the most sensible step is to raise the topic at the next routine eye examination. An eye-care professional can measure intraocular pressure and assess the optic nerve, catching early signs of glaucoma that often go unnoticed. Patients should also discuss any concerns with the physician who prescribed the medication before making changes. Regular comprehensive eye exams remain the single most reliable safeguard, regardless of medication use.